Belpointe Asset Management LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1721242
RENO, NV
Position in VRTX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,239,595
-$655,449 QoQ
Shares Held
2,776
-33.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 28.674351585014406.ToString("F0")%
Shared 71.3256484149856.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Belpointe Asset Management LLC holds $7,054,376 across 13 Biotechnology names. VRTX ranks #3 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
34,042 | $1,729,333 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,213 | $1,709,852 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,776 | $1,239,595 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
15,088 | $975,137 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
38,445 | $308,713 | |
| 6 | GALT |
Galectin Therapeutics Inc
|
106,139 | $296,127 | |
| 7 | INCY |
Incyte Corp
|
2,742 | $258,077 | |
| 8 | KLRS |
Kalaris Therapeutics, Inc.
|
40,000 | $230,800 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,239,595 | 2,776 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $1,895,044 | 4,180 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $1,658,595 | 4,235 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $1,682,856 | 3,780 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $1,941,704 | 4,005 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $491,696 | 1,221 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $579,954 | 1,247 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $516,529 | 1,102 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $428,878 | 1,026 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $296,622 | 729 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $236,115 | 679 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $323,405 | 919 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $477,015 | 1,514 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,404,914 | 4,865 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,005,643 | 6,927 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,503,067 | 5,334 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,479,177 | 5,668 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,312,768 | 5,978 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,033,378 | 5,697 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,096,665 | 5,439 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $976,030 | 4,542 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $258,319 | 1,093 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $201,096 | 739 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $580,039 | 1,998 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $404,990 | 1,702 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||